Venetoclax shows potential for R/R hairy cell leukemia

Published Date: 13 Mar 2023

Five out of six patients with relapsed or recurrent lymphoma responded to venetoclax alone or in combination with rituximab.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Patients with head and neck cancer who cannot receive cisplatin now have new hope.

2.

The Boom in ADHD Coaching Has Few Rules

3.

Q&A: Why adolescents and young adults with cancer are falling behind

4.

Adaptive SABR-Used Hypofractionated Chemoradiation Showed Good Results in NSCLC.

5.

Making informed decisions and managing regret after prostate cancer treatment


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot